A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health: A Good Practices Report of an ISPOR Task ForceJohn F. P. Bridges, Deborah A. Marshall, Esther W. de Bekker‐Grob et al.|Value in Health|2023Cited by 80
Risk Prediction Scores for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: An International Validation in Primary TumoursMoniek M. Vedder, Ewout W. Steyerberg, Mirari Márquez et al.|PLoS ONE|2014Cited by 66
Non‐muscle‐invasive bladder cancer surveillance for which cystoscopy is partly replaced by microsatellite analysis of urine: a cost‐effective alternative?Esther W. de Bekker‐Grob, Ewout W. Steyerberg, Madelon N.M. van der Aa et al.|British Journal of Urology|2008Cited by 46
<i>FGFR3</i> Mutation Analysis in Voided Urine Samples to Decrease Cystoscopies and Cost in Nonmuscle Invasive Bladder Cancer Surveillance: A Comparison of 3 StrategiesKim E.M. van Kessel, Ewout W. Steyerberg, Lucie C. Kompier et al.|The Journal of Urology|2012Cited by 33
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluationsDon Husereau, Richard Edlin, Michael Drummond et al.|The European Journal of Health Economics|2022Cited by 29